Jupiter Life Lin

Jupiter Life Line Hospitals reported strong financial performance for Q3 FY25, with income growing 17.7% YoY to Rs. 322 crores and EBITDA increasing 21.5% YoY to Rs. 76.4 crores, achieving a 23.7% margin. PAT also saw a 20.1% YoY rise to Rs. 52.5 crores. For the nine months ended December 31, 2024, revenue stood at Rs. 934.8 crores (up 19.5% YoY) and EBITDA at Rs. 218.3 crores (up 22% YoY), with a 23.4% margin. The ARPOB for Q3 FY25 was Rs. 61,750, and the occupancy rate was 65.7%.

The company announced the acquisition of a 2-acre land plot in Mira Road for approximately Rs. 75 crores, financed through internal accruals and equity reserves. This site will host a new 300-bed multi-specialty quaternary care hospital with an estimated CAPEX of Rs. 400 crores, expected to be operational by Calendar Year 2029. Additionally, the second Pune hospital in Bibvewadi received regulatory approvals, with construction for its 200-bed first phase set to begin in March 2025, targeting Calendar Year 2028 for operations. The Indore hospital recently added 78 beds, bringing its total capacity to 309 beds, ahead of schedule and under Rs. 25 crores CAPEX. The Dombivli project is progressing as planned for a Q1 FY26-27 operational date.

Management outlined a strategy to fund the estimated Rs. 1400 crores CAPEX for the three new greenfield hospitals (Dombivli, Pune 2, Mira Road) entirely through internal accruals and existing cash reserves, aiming to maintain a debt-free status. The company currently holds approximately Rs. 250 crores in cash, and its 9M FY25 EBITDA was Rs. 218.3 crores, providing confidence in its ability to self-finance expansion. Initial P&L impact for new greenfield hospitals is expected to be EBITDA negative in the first year, breaking even in the second, and becoming positive in the third.

For the nine months, ARPOB increased to Rs. 59,100 from Rs. 53,600 in the prior year, while the average length of stay (ALOS) slightly improved to 3.88 days from 3.92 days. Occupancy for the nine months rose to 66.7% from 63.2% last year, with overall volume increasing from 6,51,500 to 7,27,500. The payer mix for the period was 55.4% from insurance, 43.5% from self-payers, and 1.1% from government schemes, indicating a strong reliance on private and insured patients.

In Thane, management believes the market's 3 million population and existing medical talent pool are sufficient to absorb new competition without impacting Jupiter's operations, citing high inherent demand and the replacement of unorganized care with organized multi-specialty hospitals. The new Mira Road hospital is strategically located in a densely populated residential area (Mira Bhayandar, Dahisar, Vasai Virar regions) with an unmet demand for high-end healthcare facilities, where residents currently travel to Thane or Mumbai for advanced treatment.